XML 19 R52.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

SUPPLEMENTARY DATA (UNAUDITED) (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract] |
Schedule of quarterly financial information | Selected unaudited quarterly consolidated financial data are shown below:
|  | 2019
(in millions, except per share amounts) |  | First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
Revenue |  | $ | 2,016 |  |  | $ | 2,152 |  |  | $ | 2,209 |  |  | $ | 2,224 |
Expenses |  | 1,729 |  |  | 1,895 |  |  | 1,880 |  |  | 3,300 |
Operating income (loss) |  | $ | 287 |  |  | $ | 257 |  |  | $ | 329 |  |  | $ | (1,076 | )
Net loss attributable to Bausch Health Companies Inc. |  | $ | (52 | ) |  | $ | (171 | ) |  | $ | (49 | ) |  | $ | (1,516 | )
Basic and Diluted loss per share attributable to Bausch Health Companies Inc.: |  | $ | (0.15 | ) |  | $ | (0.49 | ) |  | $ | (0.14 | ) |  | $ | (4.30 | )
Net cash provided by operating activities |  | $ | 413 |  |  | $ | 339 |  |  | $ | 515 |  |  | $ | 234 |
|  | 2018
(in millions, except per share amounts) |  | First Quarter |  | Second Quarter |  | Third Quarter |  | Fourth Quarter
Revenue |  | $ | 1,995 |  |  | $ | 2,128 |  |  | $ | 2,136 |  |  | $ | 2,121 |
Expenses |  | 4,276 |  |  | 2,373 |  |  | 2,019 |  |  | 2,096 |
Operating (loss) income |  | $ | (2,281 | ) |  | $ | (245 | ) |  | $ | 117 |  |  | $ | 25 |
Net loss attributable to Bausch Health Companies Inc. |  | $ | (2,581 | ) |  | $ | (873 | ) |  | $ | (350 | ) |  | $ | (344 | )
Basic and Diluted loss per share attributable to Bausch Health Companies Inc.: |  | $ | (7.36 | ) |  | $ | (2.49 | ) |  | $ | (1.00 | ) |  | $ | (0.98 | )
Net cash provided by operating activities |  | $ | 438 |  |  | $ | 222 |  |  | $ | 522 |  |  | $ | 319 |

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=118952077&loc=d3e1280-108306 + Details
Name: | us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration